Home › Urogenital Cancer › New York
Urogenital Cancer clinical trials in New York
4 studies for Urogenital Cancer are looking for participants at sites in New York.
Cities in New York
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- The Feinstein Institutes for Medical Research, Lake Success
- NYU Grossman School of Medicine, New York
- SUNY Upstate, Syracuse
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Memorial Sloan Kettering Cancer Center, Long Island City
- Associated Medical Professionals, Syracuse
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT06800313A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- START New York Long Island, LLC, New Hyde Park
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
- and 1 more
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 9, 2026 · NCT07103018From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.